Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 387 of 6351
-
Promising drug cocktail aims to shrink penile cancer before surgery
Disease control Recruiting nowThis clinical study is a Phase II research trial focused on a new preoperative treatment for men with advanced penile squamous cell carcinoma (a type of penile cancer). The cancer may be hard to treat with penile-sparing surgery, or it may have spread to nearby lymph nodes (like …
Phase 2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a four-pronged attack shrink liver tumors enough for surgery?
Disease control Not yet recruitingEfficacy and safety of retlirafusp alfa combined with bevacizumab and chemotherapy with or without short-course radiotherapy in conversion therapy for advanced colorectal cancer liver metastases: an exploratory study.
Phase 2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could J147 help stroke patients recover better?
Disease control Recruiting nowThe goal of this clinical trial is to find out if the drug J147 improves outcomes for persons who have had an ischemic stroke. It also will learn about the safety of J147 when given by injection to stroke patients. Researchers will compare the outcomes of those who receive J147 a…
Phase 2 • Sponsor: Abrexa Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Promising new combo for tough lung cancer: Low-Dose radiation plus immunotherapy
Disease control Not yet recruitingThis study is a multicenter, prospective investigation aiming to evaluate the efficacy and safety of low-dose radiotherapy (15Gy/1.5 Gy bid × 10 fractions) combined with 4-6 cycles of systemic chemotherapy concurrently with Adebrelimab, followed by Adebrelimab maintenance therapy…
Phase 2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a radioactive compound outsmart resistant neuroblastoma?
Disease control Recruiting nowFractionated dosing of \[211At\]MABG Radiotherapy in Relapsed/Refractory Neuroblastoma
Early phase 1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a simple drug combo stop heart disease before it starts?
Disease control Recruiting nowHeart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if screening and early treatment of mild heart disease works. PRE-EMPT will screen individuals at low 10-year risk of heart…
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a pill cut transfusions for sickle cell patients?
Disease control Recruiting nowThe primary objective of this study is to determine the effect of mitapivat versus placebo on the need for transfusions in subjects with SCD.
Phase 3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a pill replace the CPAP machine for sleep apnea?
Disease control Recruiting nowThe goal of this randomized, double-blind, multi-dose crossover clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive sleep apnea. The primary endpoint is: Change in AHI4 at the end of each treatment period compared to baseline (each trea…
Phase 2 • Sponsor: Incannex Healthcare Ltd • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New inhaled drug could ease breathing for PAH patients
Disease control Recruiting nowThe primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.
Phase 3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can an AI coach and simple exercises help cancer patients fight frailty?
Symptom relief Not yet recruitingThe goal of this randomized controlled intervention is to develop and evaluate the effectiveness of the nurse-led with AI chatbot Individualized Symptom Management Education and Home-based Exercise (AI-ISME\&HE) based on The Theory of Symptom Self-Management (TSSM) on frailty, se…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New cream could help kids with 'Butterfly Skin' heal faster
Disease control Recruiting nowThe upcoming trial is for EB patients is a topically applied whole-body treatment of patients with either Simplex, RDEB or Junctional (nH) ages 1 month to 12 years old at study entry. There are only 4 site visits by patients with minimal assessments over a 2-month period, and pat…
Phase 3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could skipping the breathing tube speed heart surgery recovery?
Disease control Recruiting nowThe goal of this prospective, multicenter, randomized clinical trial is to learn whether a nonintubated supraglottic airway anesthesia strategy with early restoration of spontaneous breathing can reduce postoperative pulmonary complications and improve early recovery in adults un…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope against superbug pneumonia: Dual-Action antibiotic trial launches
Disease control Recruiting nowStudy on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can your own blood cells boost knee pain relief?
Disease control Recruiting nowThis prospective, randomized, open-label, single-centre post-market clinical follow-up (PMCF) study evaluates the clinical performance and safety of a single intra-articular injection of hyaluronic acid (HA) combined with autologous platelet-rich plasma (PRP) compared with a sing…
Sponsor: Implai Sp z o.o • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Tiny drug particles aim to shrink breast tumors
Disease control Not yet recruitingThe goal of this clinical trial is to compare the objective response rates (ORR) of different doses of BL0175 in patients with postmenopausal hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. The…
Phase 2 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets HPV-Driven cancers in phase II trial
Disease control Not yet recruitingThis trial is a multicenter, open-label, dose exploration and cohort expansion Phase II clinical study designed to evaluate the safety, immunogenicity, and preliminary efficacy of different dosing regimens of SYS6026 injection (hereinafter referred to as "SYS6026") combined with …
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a dual immune booster plus chemo shrink hard-to-treat bile duct tumors?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether QL1706(Iparomlimab/Tuvonralimab) in combination with gemcitabine and cisplatin (GC) is effective and safe as a first-line treatment for patients with advanced biliary tract cancer whose tumors are PD-L1 positive (CPS ≥ 1). Th…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a stem cell shot rebuild Worn-Out knees?
Disease control Recruiting nowA Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial
Sponsor: Kang Stem Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a targeted drug curb the devastating attacks of NMOSD?
Disease control Recruiting nowThis study is a multicenter, prospective cohort study designed to enroll 50 NMOSD patients who receive Satralizumab treatment during the early phase of an NMOSD attack. Follow-up visits will be conducted at baseline, 3 months, and 6 months to record and assess EDSS scores, modifi…
Sponsor: Junwei Hao, MD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Facing the fear: could desensitization training unlock job interview success for people who stutter?
Symptom relief Recruiting nowStuttering is a common fluency disorder characterized by involuntary interruptions in speech flow, such as repetitions, prolongations, and blocks. It affects approximately 1% of the world's population and typically emerges in the early stages of language development, particularly…
Sponsor: DİLARA BASER • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC